Efficacy and safety of gemcitabine, oxaliplatin, and paclitaxel in cisplatin-refractory germ cell cancer in routine care—Registry data from an outcomes research project of the German Testicular Cancer Study Group

Published 2016 View Full Article

Authors

Keywords

Cisplatin-refractory germ cell cancer, Gemcitabine, Oxaliplatin, Paclitaxel, GOP chemotherapy

Journal

UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

Volume 34, Issue 4, Pages 168.e21-168.e28

Publisher

Elsevier BV

Online

2015-12-16

DOI

10.1016/j.urolonc.2015.11.007

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now